IDEAYA Biosciences Announces Inducement Grants
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, announced that the Compensation Committee of its Board of Directors granted non-qualified stock options to two newly hired employees.
The stock options are for an aggregate of 73,500 shares of the Company's common stock, with an exercise price of $31.60 per share, equal to the closing price on The Nasdaq Global Select Market on the date of grant.
No additional information was provided.
Author summary: IDEAYA Biosciences grants stock options.
More News
- Why shared ownership remains a vital tenure
- Ethics rules didn't require Sheffield to disclose relationship
- 'Argentina gradually joins the great authoritarian wave sweeping the globe'
- The power of organising and how to win the outsourcing battle | Article | News | UNISON National
- Caitlin Clark and Paige Bueckers will have star power challenged by "generational talent" in 2027
- ICE Plans Cash Rewards for Private Bounty Hunters to Locate and Track Immigrants
- Male views on masculinity are gradually shifting — and that's good for their mental health